(Companies Covered: Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, LG Life Sciences Ltd.)
The global erythropoietin (EPO) market is expected to decline from $1.01 billion in 2019 to $0.95 billion in 2020 at a compound annual growth rate of -6.27%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $2.27 billion in 2023 at a compound annual growth rate of 33.9%.
Read More On The Global Erythropoietin (EPO) Market Report At –
https://www.thebusinessresearchcompany.com/report/erythropoietin-epo-global-market-report-2020-30-covid-19-growth-and-change
The erythropoietin (EPO) market consists of sales of erythropoietin drugs by entities (organizations, sole traders, and partnerships) that manufacture erythropoietin biosimilars. Erythropoietin (EPO) is a hormone produced by kidneys and plays a vital role in the production of red blood cells, which carry oxygen from the lungs to the rest of the body. Lack of sufficient erythropoietin results in low red blood cells, which may lead to anaemia. The erythropoietin (EPO) drugs are used for treatment for anaemia, kidney disorders, cancer, and other conditions.
Global Erythropoietin (EPO) Market Segmentation –
1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others.
2) By Application: Cancer, Hematology, Renal diseases, Neurology, Others.
Global Erythropoietin (EPO) Market Driver –
Stringent regulations imposed on the production and sales of erythropoietin drugs are predicted to hinder the growth of the erythropoietin market over the forecast period.
Request For A Sample Of The Global Erythropoietin (EPO) Market Report At – https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp
Few Points From The Global Erythropoietin (EPO) Market TOC
1. Executive Summary
2. Erythropoietin (EPO) Market Characteristics
3. Erythropoietin (EPO) Market Size And Growth
3.1. Global Erythropoietin (EPO) Historic Market, 2015 – 2019, $ Billion
4. Erythropoietin (EPO) Market Segmentation
4.1. Global Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. Erythropoietin (EPO) Market Regional And Country Analysis
5.1. Global Erythropoietin (EPO) Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Erythropoietin (EPO) Market
6.1. Asia-Pacific Erythropoietin (EPO) Market Overview
6.2. Asia-Pacific Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Erythropoietin (EPO) Market
7.1. China Erythropoietin (EPO) Market Overview
7.2. China Erythropoietin (EPO) Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Media Contact
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
Address:
City: London
State: Greater London
Country: United Kingdom
Website: https://www.thebusinessresearchcompany.com/